An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: The time-dependent release of biologically active growth factors from stored blood products

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 12, 2011, Pages 1789-1794

  Upile, Tahwinder ^a,b,c,d   Jerjes, Waseem ^b,d   Mahil, Jaspal ^c,d   Upile, Navdeep ^a,c   Sudhoff, Holger ^e   Wright, Anthony ^a,c   Hopper, Colin ^b,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e Bielefeld Hospital   (Germany)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Biologically active; Cancer; Growth factors; Patient; Perioperative; Stored blood products; Transfusion; Worsened prognosis

Indexed keywords

VASCULOTROPIN;

ALLOTRANSPLANTATION; ARTICLE; BIOLEACHING; BLOOD STORAGE; BLOOD TRANSFUSION; CANCER PATIENT; CHRONOTHERAPY; ERYTHROCYTE CONCENTRATE; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; LEUKOCYTE; PERIOPERATIVE TRANSFUSION; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TUMOR CELL; UMBILICAL VEIN ENDOTHELIAL CELL; WORSENED PROGNOSIS;

BLOOD TRANSFUSION; CELL LINE, TUMOR; DISEASE PROGRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; PILOT PROJECTS; PREOPERATIVE CARE; PROGNOSIS;

EID: 83655164922     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1525-y     Document Type: Article

References (43)

1. D Francis B Shenton 1981 Blood transfusion and tumour growth: evidence from laboratory animals Lancet 2 8251 871 6116979 10.1016/S0140-6736(81)91133-8 1:STN:280:DyaL38%2FjsVykug%3D%3D (Pubitemid 11017580)
2. N Blumberg J Heal 1987 Perioperative blood transfusion and solid tumour recurrence Blood Rev 1 4 219 229 3332106 10.1016/0268-960X(87)90023-3 1:STN:280:DyaL1M%2FgtFeitg%3D%3D
3. N Blumberg J Heal 1987 Perioperative blood transfusion and solid tumor recurrence-a review Cancer Invest 5 6 615 625 3327573 10.3109/07357908709020321 1:STN:280:DyaL1c7msVCrtg%3D%3D (Pubitemid 18093489)
4. N Blumberg J Heal 1989 Transfusion and host defenses against cancer recurrence and infection Transfusion 29 3 236 245 2646766 10.1046/j.1537-2995. 1989.29389162731.x 1:STN:280:DyaL1M7mt1Ogsw%3D%3D (Pubitemid 19141902)
5. N Blumberg J Heal 1994 Effects of transfusion on immune function. Cancer recurrence and infection Arch Pathol Lab Med 118 4 371 379 8166587 1:STN:280:DyaK2c3hvF2ksQ%3D%3D (Pubitemid 24112601)
6. J Marshall 2004 Transfusion trigger: when to transfuse? Crit Care 8 2 31 33 10.1186/cc2846 (Pubitemid 39144727)
7. GH Cunha LM Matrisian 2002 It's not my fault, blame it on my microenvironment Differentiation 70 469 472 12492489 10.1046/j.1432-0436.2002. 700901.x (Pubitemid 36194312)
8. JG McFarland 1999 Perioperative blood transfusions: indications and options Chest 115 1138 1218 10.1378/chest.115.suppl-2.113S
9. L Edvardsen, et al. 2001 Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates Am J Haematol 67 157 162 10.1002/ajh.1099 1:CAS:528:DC%2BD3MXltVOgu74%3D (Pubitemid 32538612)
10. K Werther IJ Christensen HJ Nielsen 2002 Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets Scand J Clin Lab Invest 62 343 350 12387579 10.1080/00365510260296492 1:CAS:528:DC%2BD38XosFaku7s%3D
11. M Mincheff H Meryman 1995 Blood transfusion, blood storage and immunomodulation Immunol Invest 24 1-2 303 309 7713591 10.3109/08820139509062780 1:STN:280:DyaK2M3ivFansw%3D%3D
12. M Bock, et al. 1990 Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer Acta Otolaryngol 110 1-2 155 160 2386031 10.3109/00016489009122531 1:STN:280:DyaK3czltVCksA%3D%3D (Pubitemid 20206998)
13. J Bordin M Blajchman 1995 Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy Hematol Oncol Clin North Am 9 1 205 218 7737942 1:STN:280:DyaK2M3ls1Wltg%3D%3D
14. JO Bordin MA Blajchman 1999 Immunosuppressive effects of allogenic blood transfusions: implications for the patient with a malignancy Hematol Oncol Clin North Am 9 205 218
15. I Chin-Yee N Arya M d'Almeida 1997 The red cell storage lesion and its implication for transfusion Transfus Sci 18 3 447 458 10175158 10.1016/S0955-3886(97)00043-X 1:STN:280:DyaK1c%2Fps1Wgug%3D%3D (Pubitemid 27489032)
16. J Ho W Sibbald I Chin-Yee 2003 Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med 31 12 Suppl S687 S697 14724467 10.1097/01.CCM.0000099349.17094.A3 1:CAS:528:DC%2BD2cXhsVantr4%3D
17. T Upile, et al. 2008 The direct effects of stored blood products may worsen prognosis of cancer patients; shall we transfuse or not? An explanation of the adverse oncological consequences of blood product transfusion with a testable hypothesis driven experimental research protocol Med Hypotheses 71 4 489 492 18590945 10.1016/j.mehy.2008.04.027
18. T Mynster 2001 Effects of red cell storage and lysis on in vitro cytokine release Transfus Apheresis Sci 25 1 17 23 10.1016/S1473-0502(01)00081-7 1:STN:280:DC%2BD38%2FmsFGgsw%3D%3D (Pubitemid 33070546)
19. T Mynster, et al. 2000 Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Study Group Br J Surg 87 1553 1562 11091245 10.1046/j.1365-2168.2000.01570.x 1:STN:280:DC%2BD3M%2FltFOhsQ%3D%3D
20. T Mynster, et al. 1998 Immunomodulating effect of blood transfusion: is storage time important? Vox Sang 74 176 181 9595645 10.1046/j.1423-0410.1998. 7430176.x 1:CAS:528:DyaK1cXitl2qsLw%3D (Pubitemid 28167616)
21. T Mynster H Nielsen 2000 The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group Scand J Gastroenterol 35 2 212 217 10720122 10.1080/003655200750024416 1:STN:280:DC%2BD3c7otlSnsw%3D%3D (Pubitemid 30216593)
22. T Mynster HJ Nielsen D.R.C.C.S. Group 2001 Storage time of transfused blood and disease recurrence after colorectal surgery Eur J Surg 167 287 292 10.1080/110241501300091480 (Pubitemid 32336888)
23. P Offner 2004 Age of blood: does it make a difference? Crit Care 8 Suppl 2 S24 S26 15196318 10.1186/cc2405 (Pubitemid 39144725)
24. P Offner, et al. 2002 Increased rate of infection associated with transfusion of old blood after severe injury Arch Surg 137 6 711 717 12049543 10.1001/archsurg.137.6.711 (Pubitemid 34603017)
25. Y Taniguchi M Okura 2003 Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma Head Neck 25 11 931 936 14603453 10.1002/hed.10313 (Pubitemid 37323008)
26. HJ Nielsen, et al. 1999 Soluble vascular endothelial growth factor in various blood transfusion components Transfusion 39 1078 1083 10532601 10.1046/j.1537-2995.1999.39101078.x 1:CAS:528:DyaK1MXntFynsLY%3D (Pubitemid 29485323)
27. Alitalo K (2004) Vascular endothelial growth factors, Multiple roles in cancer. Meniscus Educational institute pp 1-24
28. HJ Nielsen 1995 Detrimental effects of perioperative blood transfusion Br J Surg 82 582 587 7613921 10.1002/bjs.1800820505 1:STN:280:DyaK2MzjvVKlsg%3D%3D
29. CR Ozawa, et al. 2004 Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis J Clin Invest 113 516 527 14966561 1:CAS:528:DC%2BD2cXhsFKhsb8%3D (Pubitemid 38542501)
30. J Brieger, et al. 2003 Role of the host microenvironment on the expression of VEGF-subtypes in squamous cell carcinoma Oncol Rep 10 1503 1506 12883731 1:CAS:528:DC%2BD3sXmvFWns7s%3D
31. R Folberg MJC Hendrix AJ Maniotis 2000 Vasculogenic mimicry and tumor angiogenesis Am J Pathol 156 361 381 10666364 10.1016/S0002-9440(10)64739-6 1:STN:280:DC%2BD3c7jt1yjtw%3D%3D (Pubitemid 30648785)
32. B Bussolati, et al. 2003 Altered angiogenesis and survival in human tumor derived endothelial cells FASEB J 17 1159 1160 12709414 1:CAS:528: DC%2BD3sXktl2js7w%3D
33. F Giacchino, et al. 1982 The influence of blood transfusion on cellular immunity Immunol Lett 5 5 253 257 6761266 10.1016/0165-2478(82)90108-0 1:STN:280:DyaL3s7jsVWnug%3D%3D (Pubitemid 13141211)
34. N Blumberg M Agarwal C Chuang 1985 Relation between recurrence of cancer of the colon and blood transfusion Br Med J (Clin Res Ed) 290 6474 1037 1039 10.1136/bmj.290.6474.1037 1:STN:280:DyaL2M7nsFyhsQ%3D%3D (Pubitemid 15109947)
35. N Blumberg J Heal 1989 Transfusion and recipient immune function Arch Pathol Lab Med 113 3 246 253 2645852 1:STN:280:DyaL1M7kvFertg%3D%3D (Pubitemid 19084335)
36. N Blumberg J Heal 1990 Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection Yale J Biol Med 63 5 429 433 2293502 1:STN:280:DyaK3M7lslCltg%3D%3D
37. N Blumberg D Triulzi J Heal 1990 Transfusion-induced immunomodulation and its clinical consequences Transfus Med Rev 4 4 Suppl 1 24 35 2134638 10.1016/S0887-7963(90)70239-8 1:STN:280:DyaK383gtVWjsw%3D%3D
38. A Brand 2002 Immunological aspects of blood transfusions Transpl Immunol 10 2-3 183 190 12216948 10.1016/S0966-3274(02)00064-3 1:CAS:528: DC%2BD38XlvVenuro%3D
39. E Dellinger D Anaya 2004 Infectious and immunologic consequences of blood transfusion Crit Care 8 2 S18 S23 15196317 10.1186/cc2847 (Pubitemid 39144724)
40. W Den Otter 1986 Immune surveillance and natural resistance: an evaluation Cancer Immunol Immunother 21 2 85 92 10.1007/BF00199854 (Pubitemid 16155053)
41. AAGBI (2005) Blood transfusion, the anesthetist: blood component therapy. Special supplement. The Association of Anesthetists of Great Britain and Ireland, London
42. M Blajchman P Hebert 2001 Red blood cell transfusion strategies Transfus Clin Biol 8 3 207 210 11499959 10.1016/S1246-7820(01)00136-7 1:STN:280:DC%2BD3MvltlOltA%3D%3D (Pubitemid 32672972)
43. A Greenburg 1996 Benefits and risks of blood transfusion in surgical patients World J Surg 20 9 1189 1193 8864080 10.1007/s002689900181 1:STN:280:DyaK2s%2FitVWmug%3D%3D (Pubitemid 26365680)